Physician profile
Devora Leah Stone
NPI 1992468904
$1,160.50
in general payments reported to CMS, 2019-2025
11 companies · $280 in 2025
The $280 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $81.82 · 2022: $242 · 2023: $415 · 2024: $141 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $277.52 | 2021-2022 | |
| Horizon Therapeutics Plc | $250.00 | 2023 | Krystexxa, Uplizna |
| Teva Pharmaceuticals USA, INC. | $140.00 | 2025 | |
| Exact Sciences Corporation | $121.92 | 2023 | Cologuard Collection Kit |
| Abiomed | $100.00 | 2024 | Impella |
| Genzyme Corporation | $100.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $65.86 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $46.09 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.96 | 2023 | |
| Tactile Systems Technology INC | $20.86 | 2024 | Flexitouch Plus, Entre Plus |
| E.R. Squibb & Sons, L.L.C. | $16.29 | 2025 | Reblozyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devora Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.